News
Molecular Templates Provided An Update On Its Clinical-Stage Programs
3 Jun 24
Biotech, News, Health Care, General
Molecular Templates Q1 2024 GAAP EPS $0.08 Beats $(0.78) Estimate, Sales $11.09M Beat $5.90M Estimate
15 May 24
Earnings, Earnings Beats, News
12 Health Care Stocks Moving In Tuesday's After-Market Session
9 Apr 24
Movers
What's Going On With Molecular Templates Stock?
9 Apr 24
News, Movers
Molecular Templates Presents Interim Data From MT-6402 Phase I Study In Patients With PD-L1+ Solid Tumors At 2024 AACR Annual Meeting
9 Apr 24
Biotech, News, Events, General
12 Health Care Stocks Moving In Friday's Pre-Market Session
5 Apr 24
Movers
Press releases
Molecular Templates, Inc. Provides Interim Update
3 Jun 24
Health Care, Press Releases
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
15 May 24
Earnings, Press Releases
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism
9 Apr 24
News, Press Releases
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
29 Mar 24
Earnings, Press Releases
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
28 Mar 24
News, Financing, Press Releases